Sourced from:Manufacturer Authorized Distributor
Quick Summary
Erlogis 100mg Capsule
Last updated on 31 Mar 2026 | 09:29 AM (IST)
₹3540
MRP: ₹4425
(You Save ₹885)
30 CAPSULE(s) IN A BOTTLE
Sourced from:Manufacturer Authorized Distributor
20% OFF
₹3540
MRP: ₹4,425.00
Inclusive of all taxes
20% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Introduction to Erlogis 100mg Capsule
Erlogis 100mg Capsule is an anticancer medicine containing active constituent erlotinib. It is used to treat non-small lung cancer (NSCLC) and pancreatic cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. It is usually given in combination with other anticancer medicine, gemcitabine, for patients with metastatic or advanced pancreatic cancers.
Inform the doctor if you use contact lenses, have an intolerance to sugars, history of eye problems, or if any medicines taken for clotting disorders or cholesterol. This medication can cause eye dryness and conjunctivitis and hence patients are advised to inform the history of vision problems, use of contact lenses before taking this medication. Erlogis 100mg Capsule is not recommended for adolescents and children under the age of 18. Do not take this medication with food. Use effective birth control during the treatment and for at least 2 weeks after the last dose.
Patients are advised not to smoke while being treated with Erlogis 100mg Capsule, as smoking may decrease the amount of medicine in the blood. Wear protective clothing and sunscreen while going outside. Inform the physician if the patient has any symptoms like pain in the eye, blurred vision, cough, fever, shortness of breath, severe abdominal pain, and persistent diarrhea while taking this medicine.
Uses of Erlogis 100mg Capsule
- Advanced or metastatic non-small lung cancer (NSCLC)
- Advanced or metastatic pancreatic cancer
Therapeutic Effects of Erlogis 100mg Capsule
Erlotinib prevents the activity of a protein called epidermal growth factor receptor (EFGR), a protein involved in the spread and growth of cancer cells.
Interaction of Erlogis 100mg Capsule with other drugs
Inform the doctor about any medications you are taking or have taken before the treatment
More Information about Erlogis 100mg Capsule
- Keep out of sight and reach of children.
- Store at controlled room temperature between 15°C to 30°C.
- Do not freeze.
How to consume Erlogis 100mg Capsule
Always take this medicine as prescribed by the doctor. The tablet must be taken at least one hour before or two hours after taking food.
Safety Advice for Erlogis 100mg Capsule
Breast Feeding
Do not take Erlogis 100mg Capsule if you are breastfeeding. Consult the doctor for risks and benefits.
Alcohol
Do not drink alcohol while on treatment with Erlogis 100mg capsule. Consult doctor for more advice.
Liver
This medicine is not recommended in patients with severe liver diseases. Inform the physician about any liver disorders.
Lungs
This medicine is not recommended in patients with severe lung diseases. Inform the physician if you have any kidney disorders.
Driving
Erlogis 100mg capsule do not alter your driving ability. Consult doctor for more advice.
Pregnancy
Taking Erlogis 100mg Capsule while pregnant can harm the baby. Do not take this medicine during pregnancy unless your doctor recommends taking it. Inform your doctor if you are pregnant or planning to be pregnant before taking this medicine.
Side Effects of Erlogis 100mg Capsule
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious:
- Persistent or severe diarrhea
- Pain in the eye, blurred vision
- Sudden difficulty in breathing accompanied by cough and fever
- Severe pain in your abdomen
- Liver failure
Common:
- Rash, worsened in sun-exposed areas
- Loss of appetite, decreased weight
- Infection
- Headache
- Depression
- Nausea
- Mouth irritation
- Indigestion
- Hair loss, dry skin, itching, acne, cracked skin
- Tiredness
- Inflammation around fingernail
- Bleeding from nose, stomach, intestines
- Reduced kidney function
Word of Advice
Inform the doctor if you have vision problems, are using contact lenses, clotting disorders, intolerance to sugar and taking any medication for cholesterol before starting this medication. This medication should not be taken along with the food and it can be taken either before or after food as it increases the effectiveness of the medication. It is not recommended for individuals below 18 years of age. Inform the doctor about kidney, liver disorders as this medication is not recommended in the patient’s with kidney and liver disorders. Avoid making plans to have children or during pregnancy because this medicine is highly unsafe and causes harmful effects on the developing baby.
FAQs about Erlogis 100mg Capsule
Q1.
How should I take Erlogis 100mg Capsule?
Always take this medicine as prescribed by the doctor.The tablet must be taken at least one hour before or two hours after taking food and it should be taken at a fixed time daily.
Q2.
Does Erlogis 100mg Capsule cause eye dryness?
Yes, this medication can cause eye dryness and conjunctivitis and hence patients are advised to inform the history of vision problems, use of contact lenses before taking this medication.
Q3.
Can I take Erlogis 100mg Capsule during pregnancy?
This medication is highly unsafe in pregnancy as it can cause harmful effects in the developing baby. Avoid making plans to have children or during pregnancy while taking this medication.
Q4.
Can I smoke while taking Erlogis 100mg Capsule?
Avoid smoking while taking this medication, as it can decrease the effectiveness of this medication.
Q5.
How long can I take Erlogis 100mg Capsule?
Erlogis 100mg Capsule is taken daily as long as prescribed by the doctor and duration of time varies from patient to patient depending upon the severity of the disease.
Q6.
Can Erlogis 100mg Capsule be used in kidney disorders?
This medication is not recommended in kidney patients as it can worsen the condition of the disease.
Fact Box of Erlogis 100mg Capsule
Molecule name: Erlotinib
| Therapeutic class: Tyrosine kinase inhibitor |
Pharmacological class: Anti-Neoplastics | Indications: 1. Advanced or metastatic non-small lung cancer (NSCLC) 2. Advanced or metastatic pancreatic cancer |
References
1. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines, 12th edition, 2011, 1735-1737.
2. Mylan, Electronic medicines compendium (emc), [ Revised on Jan 2020] [ Accessed on 14th April 2021], https://www.medicines.org.uk/emc/files/pil.11264.pdf
3. Genentech, US Food and Drug Administration, [ Revised on April 2010] [ Accessed on 14th April 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021743s14s16lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Vijayalakshmi N.
BDS
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:29 AM (IST)
Want to know more?
Read Our Editorial Policy